A California-based biotech company is finding early success on Tuesday after the company announced positive preliminary data of Vebreltinib in patients with non-CNS met fusion...

To read the full story on AllPennyStocks.com, click here.

Apollomics (NASDAQ:APLM)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Apollomics Charts.
Apollomics (NASDAQ:APLM)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Apollomics Charts.